Paper2188586
Activity of sulbactam in combination with ceftriaxone in vitro and in experimental endocarditis caused by Escherichia coli producing SHV-2-like beta-lactamase.
Fantin B and 9 others. Antimicrob Agents Chemother, 1990. Cited by 44 papers, by iCite.
Cite this record
ConductScience Library. Activity of sulbactam in combination with ceftriaxone in vitro and in experimental endocarditis caused by Escherichia coli producing SHV-2-like beta-lactamase. Papers, record 2188586. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/2188586
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Activity of sulbactam in combination with ceftriaxone in vitro and in experimental endocarditis caused by Escherichia coli producing SHV-2-like beta-lactamase.
- PubMed
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Ceftriaxone | Major topic |
| Endocarditis, Bacterial | Major topic |
| Escherichia coli | Major topic |
| Escherichia coli Infections | Major topic |
| Sulbactam | Major topic |
| beta-Lactamase Inhibitors | Major topic |
| Animals | |
| Drug Combinations | |
| Female | |
| Microbial Sensitivity Tests | |
| Netilmicin | |
| Rabbits |
Source PubMed
References19
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 848924 | Microdilution transfer plate technique for determining in vitro synergy of antimicrobial agents. | Antimicrob Agents Chemother | 1977 | https://conductscience.org/library/papers/848924 | PubMed |
| 2 | 6416161 | Properties of PSE-2 beta-lactamase and genetic basis for its production in Pseudomonas aeruginosa. | Antimicrob Agents Chemother | 1983 | https://conductscience.org/library/papers/6416161 | PubMed |
| 3 | 7447427 | Method of reliable determination of minimal lethal antibiotic concentrations. | Antimicrob Agents Chemother | 1980 | https://conductscience.org/library/papers/7447427 | PubMed |
| 4 | 6268715 | Efficacy of ampicillin plus a beta-lactamase inhibitor (CP-45,899) in experimental endocarditis due to Staphylococcus aureus. | J Infect Dis | 1981 | https://conductscience.org/library/papers/6268715 | PubMed |
| 5 | 6307964 | Pharmacokinetics and bioavailability of sultamicillin estimated by high performance liquid chromatography. | J Antimicrob Chemother | 1983 | https://conductscience.org/library/papers/6307964 | PubMed |
| 6 | 3879659 | Evolution of plasmid-coded resistance to broad-spectrum cephalosporins. | Antimicrob Agents Chemother | 1985 | https://conductscience.org/library/papers/3879659 | PubMed |
| 7 | 3026019 | Sulbactam plus ampicillin: interim review of efficacy and safety for therapeutic and prophylactic use. | Rev Infect Dis | 1986 | https://conductscience.org/library/papers/3026019 | PubMed |
| 8 | 3579254 | Ion pair high-performance liquid chromatographic assay for ceftriaxone. | Antimicrob Agents Chemother | 1987 | https://conductscience.org/library/papers/3579254 | PubMed |
| 9 | 3300530 | Comparative efficacy of cefotiam, cefmenoxime, and ceftriaxone in experimental endocarditis and correlation with pharmacokinetics and in vitro efficacy. | Antimicrob Agents Chemother | 1987 | https://conductscience.org/library/papers/3300530 | PubMed |
| 10 | 2886766 | Transferable enzymatic resistance to third-generation cephalosporins during nosocomial outbreak of multiresistant Klebsiella pneumoniae. | Lancet | 1987 | https://conductscience.org/library/papers/2886766 | PubMed |
| 11 | 3324957 | Value of antibiotic levels in serum and cardiac vegetations for predicting antibacterial effect of ceftriaxone in experimental Escherichia coli endocarditis. | Antimicrob Agents Chemother | 1987 | https://conductscience.org/library/papers/3324957 | PubMed |
| 12 | 3360686 | Synergy between clavulanic acid and newer beta-lactams on nine clinical isolates of Klebsiella pneumoniae, Escherichia coli and Salmonella typhimurium resistant to third-generation cephalosporins. | J Antimicrob Chemother | 1988 | https://conductscience.org/library/papers/3360686 | PubMed |
| 13 | 3055176 | Inducible beta-lactamases: clinical and epidemiologic implications for use of newer cephalosporins. | Rev Infect Dis | 1988 | https://conductscience.org/library/papers/3055176 | PubMed |
| 14 | 3263690 | Extended broad-spectrum beta-lactamases conferring transferable resistance to newer beta-lactam agents in Enterobacteriaceae: hospital prevalence and susceptibility patterns. | Rev Infect Dis | 1988 | https://conductscience.org/library/papers/3263690 | PubMed |
| 15 | 2665645 | Ceftriaxone-netilmicin combination in single-daily-dose treatment of experimental Escherichia coli endocarditis. | Antimicrob Agents Chemother | 1989 | https://conductscience.org/library/papers/2665645 | PubMed |
| 16 | 2679367 | Extended-spectrum beta-lactamases. | Antimicrob Agents Chemother | 1989 | https://conductscience.org/library/papers/2679367 | PubMed |
| 17 | 6350256 | Escherichia coli and Klebsiella pneumoniae strains more susceptible to cefoxitin than to third generation cephalosporins. | J Antimicrob Chemother | 1983 | https://conductscience.org/library/papers/6350256 | PubMed |
| 18 | 6353526 | Emergence of resistance during therapy with the newer beta-lactam antibiotics: role of inducible beta-lactamases and implications for the future. | Rev Infect Dis | 1983 | https://conductscience.org/library/papers/6353526 | PubMed |
| 19 | 96731 | Beta-lactamases: determination of their isoelectric points. | Antimicrob Agents Chemother | 1978 | https://conductscience.org/library/papers/96731 | PubMed |
Cited by20
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 44 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 31170287 | Inoculum effect of β-lactam antibiotics. | J Antimicrob Chemother | 2019 | https://conductscience.org/library/papers/31170287 | PubMed |
| 24321187 | A multicentre clinical study on the injection of ceftriaxone/sulbactam compared with cefoperazone/sulbactam in the treatment of respiratory and urinary tract infections. | Ann Clin Microbiol Antimicrob | 2013 | https://conductscience.org/library/papers/24321187 | PubMed |
| 16223952 | Extended-spectrum beta-lactamases: a clinical update. | Clin Microbiol Rev | 2005 | https://conductscience.org/library/papers/16223952 | PubMed |
| 11585791 | Extended-spectrum beta-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat. | Clin Microbiol Rev | 2001 | https://conductscience.org/library/papers/11585791 | PubMed |
| 11376058 | Outcome of cephalosporin treatment for serious infections due to apparently susceptible organisms producing extended-spectrum beta-lactamases: implications for the clinical microbiology laboratory. | J Clin Microbiol | 2001 | https://conductscience.org/library/papers/11376058 | PubMed |
| 10081693 | Extended-spectrum beta-lactamase-producing Salmonella enteritidis in Trinidad and Tobago. | Emerg Infect Dis | 1999 | https://conductscience.org/library/papers/10081693 | PubMed |
| 9230382 | Detection and clinical significance of extended-spectrum beta-lactamases in a tertiary-care medical center. | J Clin Microbiol | 1997 | https://conductscience.org/library/papers/9230382 | PubMed |
| 9145868 | Efficacies of piperacillin-tazobactam and cefepime in rats with experimental intra-abdominal abscesses due to an extended-spectrum beta-lactamase-producing strain of Klebsiella pneumoniae. | Antimicrob Agents Chemother | 1997 | https://conductscience.org/library/papers/9145868 | PubMed |
| 9087477 | Importance of beta-lactamase inhibitor pharmacokinetics in the pharmacodynamics of inhibitor-drug combinations: studies with piperacillin-tazobactam and piperacillin-sulbactam. | Antimicrob Agents Chemother | 1997 | https://conductscience.org/library/papers/9087477 | PubMed |
| 8789016 | Hospital outbreak of Klebsiella pneumoniae resistant to broad-spectrum cephalosporins and beta-lactam-beta-lactamase inhibitor combinations by hyperproduction of SHV-5 beta-lactamase. | J Clin Microbiol | 1996 | https://conductscience.org/library/papers/8789016 | PubMed |
| 8195380 | Detection of Klebsiella pneumoniae and Escherichia coli strains producing extended-spectrum beta-lactamases. | J Clin Microbiol | 1994 | https://conductscience.org/library/papers/8195380 | PubMed |
| 7625813 | In vitro activities of various beta-lactam antimicrobial agents against clinical isolates of Escherichia coli and Klebsiella spp. resistant to oxyimino cephalosporins. | Antimicrob Agents Chemother | 1995 | https://conductscience.org/library/papers/7625813 | PubMed |
| 2128443 | Importance of the aminoglycoside dosing regimen in the penicillin-netilmicin combination for treatment of Enterococcus faecalis-induced experimental endocarditis. | Antimicrob Agents Chemother | 1990 | https://conductscience.org/library/papers/2128443 | PubMed |
| 2073099 | Ceftriaxone-sulbactam combination in rabbit endocarditis caused by a strain of Klebsiella pneumoniae producing extended-broad-spectrum TEM-3 beta-lactamase. | Antimicrob Agents Chemother | 1990 | https://conductscience.org/library/papers/2073099 | PubMed |
| 1952834 | More extended-spectrum beta-lactamases. | Antimicrob Agents Chemother | 1991 | https://conductscience.org/library/papers/1952834 | PubMed |
| 1929273 | Efficacy of different beta-lactams against an extended-spectrum beta-lactamase-producing Klebsiella pneumoniae strain in the rat intra-abdominal abscess model. | Antimicrob Agents Chemother | 1991 | https://conductscience.org/library/papers/1929273 | PubMed |
| 1834013 | Influence of low-level resistance to vancomycin on efficacy of teicoplanin and vancomycin for treatment of experimental endocarditis due to Enterococcus faecium. | Antimicrob Agents Chemother | 1991 | https://conductscience.org/library/papers/1834013 | PubMed |
| 1510412 | In vivo antibiotic synergism: contribution of animal models. | Antimicrob Agents Chemother | 1992 | https://conductscience.org/library/papers/1510412 | PubMed |
| 1444286 | Pharmacokinetic and pharmacodynamic requirements for antibiotic therapy of experimental endocarditis. | Antimicrob Agents Chemother | 1992 | https://conductscience.org/library/papers/1444286 | PubMed |
| 1329634 | Piperacillin, tazobactam, and gentamicin alone or combined in an endocarditis model of infection by a TEM-3-producing strain of Klebsiella pneumoniae or its susceptible variant. | Antimicrob Agents Chemother | 1992 | https://conductscience.org/library/papers/1329634 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/2188586
GET https://conductscience.org/api/papers/v1/2188586/authors